Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Nandita Khera et al.|Bone Marrow Transplantation|2015Cited by 185
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Mark C. Walters, Emanuele Angelucci et al.|Biology of Blood and Marrow Transplantation|2017Cited by 85
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J. Rotz, Rachel Phelan, Neel S. Bhatt et al.|Transplantation and Cellular Therapy|2024Cited by 62
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCTAndrew C. Dietz, Blanche P. Alter, Sharon A. Savage et al.|Biology of Blood and Marrow Transplantation|2017Cited by 61